共 242 条
[1]
Al-Batran S-E(2019)Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial The Lancet 393 1948-1957
[2]
Homann N(2019)Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications Lancet Oncol 20 e368-e377
[3]
Pauligk C(2014)Surgical management of microscopic positive resection margin after gastrectomy for gastric cancer: a systematic review of gastric R1 management Anticancer Res 34 6283-6288
[4]
Goetze TO(2014)Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value World J Gastroenterol WJG 20 5679-5684
[5]
Meiler J(2013)Association of positive transection margins with gastric cancer survival and local recurrence Ann Surg Oncol 20 2663-2668
[6]
Kasper S(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[7]
Alyami M(2019)Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer—a systematic review J Clin Med 8 1685-293
[8]
Hübner M(1999)Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management Jpn J Clin Oncol 29 291-468
[9]
Grass F(2014)Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients Med Oncol Northwood Lond Engl 31 159-20
[10]
Bakrin N(2007)Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single institute J Surg Oncol 95 461-213